Lung Cancer Clinical Trial
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Is eligible for LDCT for LCS follow-up
Has technology to complete study activities (e.g., video call visit)
Has undergone LCS at UMMH
Is overdue for LDCT follow-up
Has previous diagnosis of lung cancer
Has active cancer diagnosis
Is a nursing home or group care resident
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Worcester Massachusetts, 01655, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.